Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 67

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Genetic analysis of long-term Barrett’s esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities

Palanca-Wessels, M.Corinna, Barrett, Michael T., Galipeau, Patricia C., Rohrer, Katherine L., Reid, Brian J., Rabinovitch, Peter S.·1998·Gastroenterology
DOI 10.1016/s0016-5085(98)70480-9
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0016-5085(98)70480-9

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 43

  1. Spechler, 1986, Barrett's esophagus, N Engl J Med, 315, 362, 10.1056/NEJM198608073150605 · DOI
  2. Hesketh, 1989, The increasing frequency of adenocarcinoma of the esophagus, Cancer, 64, 526, 10.1002/1097-0142(19890715)64:2<526::AID-CNCR2820640228>3.0.CO;2-B · DOI
  3. Blot, 1991, Rising incidence of adenocarcinoma of the esophagus and gastric cardia, JAMA, 265, 1287, 10.1001/jama.265.10.1287 · DOI
  4. Rusch, 1994, The management of high-grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem, Cancer, 74, 1225, 10.1002/1097-0142(19940815)74:4<1225::AID-CNCR2820740408>3.0.CO;2-Q · DOI
  5. Paraf, 1995, Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases, Am J Surg Pathol, 19, 183, 10.1097/00000478-199502000-00007 · DOI
  6. Levine, 1993, An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus, Gastroenterology, 105, 40, 10.1016/0016-5085(93)90008-Z · DOI
  7. Clark, 1996, Dysplasia in Barrett's esophagus: diagnosis, surveillance and treatment, Dig Dis Sci, 14, 213, 10.1159/000171554 · DOI
  8. Rice, 1993, Surgical management of high-grade dysplasia in Barrett's esophagus, Am J Gastroenterol, 88, 1832
  9. Neshat, 1994, Barrett's esophagus: a model of human neoplastic progression, Cold Spring Harb Symp Quant Biol, 59, 577, 10.1101/SQB.1994.059.01.065 · DOI
  10. Reid, 1996, Barrett's esophagus: ordering the events that lead to cancer, Eur J Cancer Prev, 5, 57, 10.1097/00008469-199612002-00009 · DOI
  11. Reid, 1991, Barrett's esophagus and esophageal adenocarcinoma, Gastroenterol Clin North Am, 20, 817, 10.1016/S0889-8553(21)00590-2 · DOI
  12. Reid, 1992, Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort, Gastroenterology, 102, 1212, 10.1016/0016-5085(92)90758-Q · DOI
  13. Reid, 1993, Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression, Gastroenterology, 105, 119, 10.1016/0016-5085(93)90017-7 · DOI
  14. Barrett, 1996, Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms, Oncogene, 12, 1873
  15. Neshat, 1994, p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia, Gastroenterology, 106, 1589, 10.1016/0016-5085(94)90415-4 · DOI
  16. Blount, 1994, 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy, Cancer Res, 54, 2292
  17. Barrett, 1996, Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus, Oncogene, 13, 1867
  18. Galipeau, 1996, 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus, Proc Natl Acad Sci USA, 93, 7081, 10.1073/pnas.93.14.7081 · DOI
  19. Washington, 1994, Tissue culture of epithelium derived from Barrett's oesophagus, Gut, 35, 879, 10.1136/gut.35.7.879 · DOI
  20. Garewal, 1992, Tissue culture of epithelial cells from esophageal specialized columnar epithelium (Barrett's esophagus), Dig Dis Sci, 37, 532, 10.1007/BF01307576 · DOI
  21. Wang, 1996, Primary culture of Barrett's esophageal epithelium using endoscopic biopsies (abstr), Gastroenterology, 110, A291
  22. Garewal, 1989, Chromosomal rearrangements in Barrett's esophagus, Cancer Genet Cytogenet, 42, 281, 10.1016/0165-4608(89)90096-4 · DOI
  23. Garewal, 1990, Epidermal growth factor receptor overexpression and trisomy 7 in a case of Barrett's esophagus, Dig Dis Sci, 35, 1115, 10.1007/BF01537584 · DOI
  24. Garewal, 1992, Chemopreventive studies in Barrett's esophagus: a model premalignant lesion for esophageal adenocarcinoma, Monogr Natl Cancer Inst, 13, 51
  25. Zhang, 1992, Whole genome amplification from a single cell: implications for genetic analysis, Proc Natl Acad Sci USA, 89, 5847, 10.1073/pnas.89.13.5847 · DOI
  26. Barrett, 1995, Genotypic analysis of multiple loci in somatic cells by whole genome amplification, Nucleic Acids Res, 23, 3368, 10.1093/nar/23.17.3488 · DOI
  27. Boch, 1997, Distribution of cytokeratin markers in Barrett's specialized columnar epithelium, Gastroenterology, 112, 760, 10.1053/gast.1997.v112.pm9041237 · DOI
  28. Salo, 1996, Cytokeratin profile suggests metaplastic epithelial transformation in Barrett's oesophagus, Ann Med, 28, 305, 10.3109/07853899608999085 · DOI
  29. Levine, 1989, Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium, Gastroenterology, 96, 355, 10.1016/S0016-5085(89)91559-X · DOI
  30. Raskind, 1992, Persistent clonal areas and clonal expansion in Barrett's esophagus, Cancer Res, 52, 2946
  31. Rabinovitch, 1988, Progression to cancer in Barrett's esophagus is associated with genomic instability, Lab Invest, 60, 65
  32. Mirvish, 1993, Metabolism of carcinogenic nitrosamines in the rat and human esophagus and induction of esophageal adenocarcinoma in rats, Endoscopy, 25, 627, 10.1055/s-2007-1010418 · DOI
  33. Pera, 1993, Influence of pancreatic and biliary reflux on the development of esophageal carcinoma, Ann Thorac Surg, 55, 1386, 10.1016/0003-4975(93)91077-Z · DOI
  34. Carder, 1993, Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer, Oncogene, 8, 1397
  35. Levine, 1991, Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer, Proc Natl Acad Sci USA, 88, 6427, 10.1073/pnas.88.15.6427 · DOI
  36. Cross, 1995, A p53-dependent mouse spindle checkpoint, Science, 267, 1353, 10.1126/science.7871434 · DOI
  37. Fukasawa, 1996, Abnormal centrosome amplification in the absence of p53, Science, 271, 1744, 10.1126/science.271.5256.1744 · DOI
  38. Bischoff, 1996, An adenovirus mutant that replicates selectively in p53-deficient human tumor cells, Science, 274, 373, 10.1126/science.274.5286.373 · DOI
  39. Fan, 1995, Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline, Cancer Res, 55, 1649
  40. Hawkins, 1996, Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents, Cancer Res, 56, 892
  41. Powell, 1995, Radiosensitization of p53(−) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay, Cancer Res, 55, 1643
  42. Russell, 1995, Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells, Cancer Res, 55, 1639
  43. Quelle, 1995, Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest, Cell, 83, 993, 10.1016/0092-8674(95)90214-7 · DOI · Paper page

Cited by

Metadata

Authors
Palanca-Wessels, M. C., Barrett, M. T., Galipeau, P. C., Rohrer, K. L., Reid, B. J., & Rabinovitch, P. S.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
1998-02
Volume
114
Issue
2
Pages
295-304
ISSN
0016-5085
DOI
10.1016/s0016-5085(98)70480-9
Cited by
67
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review